Long-term outcomes of daily oral vs. pulsed intravenous cyclophosphamide in a non-trial setting in ANCA-associated vasculitis

Overview of attention for article published in Clinical Rheumatology, December 2017

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (69th percentile)
Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

twitter: 1 X user

patent: 2 patents

Citations

dimensions_citation: 18 Dimensions

Readers on

mendeley: 27 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

Humanized complement 5A receptor 1 antibodies and methods of use thereof

Grant US-11912781-B2

United States of America

Antibody molecules to C5aR1 and uses thereof

Grant US-11773179-B2

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.